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Abstract
Background: Consumer use of herbal and natural products (H/NP) is increasing, yet physicians are often
unprepared to provide guidance due to lack of educational training. This knowledge deficit may place consumers
at risk of clinical complications. We wished to evaluate the impact that a natural medicine clinical decision tool has
on faculty attitudes, practice experiences, and needs with respect to H/NP.
Methods: All physicians and clinical staff (nurse practitioners, physicians assistants) (n = 532) in departments of
Pediatrics, Family and Community Medicine, and Internal Medicine at our medical center were invited to complete
2 electronic surveys. The first survey was completed immediately before access to a H/NP clinical-decision tool was
obtained; the second survey was completed the following year.
Results: Responses were obtained from 89 of 532 practitioners (16.7%) on the first survey and 87 of 535 (16.3%)
clinicians on the second survey. Attitudes towards H/NP varied with gender, age, time in practice, and training. At
baseline, before having an evidence-based resource available, nearly half the respondents indicated that they rarely
or never ask about H/NP when taking a patient medication history. The majority of these respondents (81%)
indicated that they would like to learn more about H/NP, but 72% admitted difficulty finding evidence-based
information. After implementing the H/NP tool, 63% of database-user respondents indicated that they now ask
patients about H/NP when taking a drug history. Compared to results from the baseline survey, respondents who
used the database indicated that the tool significantly increased their ability to find reliable H/NP information (P <
0.0001), boosted their knowledge of H/NP (p < 0.0001), and increased their confidence in providing accurate H/NP
answers to patients and colleagues (P < 0.0001).
Conclusions: Our results demonstrate healthcare provider knowledge and confidence with H/NP can be improved
without costly and time-consuming formal H/NP curricula. Yet, it will be challenging to make providers aware of
such resources.
Background
Use of natural and herbal products (H/NP) has experi-
enced a resurgence in the United States since passing of
the Dietary Supplement Health Education Act (DSHEA)
in 1994 [1]. Less than two decades ago, only 4,000 H/NP
were available in the United States; today, there are more
than 30,000 products, with more than 1,000 new options
added each year [1,2]. According to DSHEA, dietary
supplements include vitamins, minerals, herbs or other
botanicals, amino acids, other dietary substances for use
by man that are intended to supplement the diet, as well
as concentrates, metabolites, constituents, extracts, or
combinations of these ingredients. Presently, almost one
fifth of the adult population of the United States admits to
using non-vitamin, non-mineral dietary supplements [3].
It is estimated that US consumers spend more than $15
billion each year on these products [4].
Given the popularity of H/NP, minimal premarket safety
or efficacy requirements, and often unsubstantiated health
claims, healthcare providers need to be knowledgeable
about many different supplements or have access to
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risks and benefits of these products. Studies have shown
that consumers are often misinformed about the H/NP
therapies they are using, and they may be at risk of harm
[5-7]. Few users of H/NP tell their physicians about the
dietary supplements they are using partly because doctors
do not consistently inquire about alternative therapies,
and in part, because patients do not perceive healthcare
professionals to be knowledgeable about H/NP [8,9].
Additionally, patients do not tell their physicians about the
H/NP they use due to fear that their physicians will disap-
prove [8,9]. Failure to disclose use of dietary supplements
may be an important public health issue, yet even when
consumers look to healthcare providers for guidance with
dietary supplements, physicians are frequently unprepared
to effectively handle the clinical questions that arise. Lack
of formal training and inadequate or conflicting informa-
tion from manufacturers contributes to physician reluc-
tance to engage in discussions of H/NP, and physicians’
knowledge in the area of H/NP is lacking. It has previously
been shown that physicians dramatically under-estimate
the potential for these therapies to cause side effects and
interact with conventional medications [10]. Understand-
ably physicians may be hesitant to discuss H/NP when
they themselves are uncertain about the safety and efficacy
of these products [2]. As a result, many physicians disavow
use of all H/NP or take a “don’ta s k ,d o n ’t tell” approach
toward the supplements [11,12]. Yet, this tactic only alie-
nates patients who will likely use H/NP anyway, but will
subsequently avoid such discussions with their healthcare
provider. It has previously been shown that well-informed
physicians are more confident in patient interactions, and
that alone improves healthcare quality [13,14]. Thus, it is
imperative that physicians receive some education on the
H/NP related to their practice or at least have access to
evidence-based information when patient questions arise.
Unlike well-established alternative medicine centers fea-
tured at some hospitals [15-17], our medical center had
no complementary and alternative resources established at
the time this study was conceived. Therefore, our initial
objective was to assess attitudes, knowledge, professional
behaviors, and needs of clinicians with respect to H/NP.
Once we recognized the needs of our providers in this
area, our second objective was to determine the extent to
which an H/NP clinical decision tool could meet those
needs by providing evidence-based H/NP information
accessible at the point of care. We hypothesized that a
web-based tool would meet the needs that our clinicians
had expressed with regard to H/NP.
Methods
Surveys
Two surveys were prepared for physicians and clinical
staff (nurse practitioner, physician assistants) practicing
within the departments of Pediatrics (Peds), Family and
Community Medicine (FCM), and Internal Medicine
(Med) at the Penn State Milton S. Hershey Medical
Center and College of Medicine. This is an academic
medical center located in central Pennsylvania. Com-
prised of 484 licensed beds, the institution is also home
to a cancer institute with a catchment area of 27 coun-
ties, many of them underserved, as well as the region’s
only level 1 pediatric traumac e n t e r .Af o u n d i n gf o c u s
of the medical school was primary care, a situation that
remains evident even today by 35% of students entering
primary care residencies after graduation.
E-mails inviting clinicians to complete the surveys were
sent from the academic offices of departmental chairman
of Peds and FCM and from the offices of all 9 division
chiefs within the department of Med. These emails asked
all physicians (faculty and residents) and clinical staff
(nurse practitioners and physician assistants) to complete
surveys about knowledge, attitudes, and experiences with
H/NP. The emails contained a direct link to the surveys,
which were developed using SurveyMonkey such that the
data could be collected and stored anonymously.
Responses from nurse practitioners and physician assis-
tants were included in our dataset since these allied
healthcare providers play key roles in patient care, thus
the terms “provider” and “clinician” in our data analysis
refer to any of the physicians or allied health care provi-
ders that are licensed as MDs, DOs, PAs, and NPs.
The nature of each survey was explained in the emails
and again when physicians accessed the link. Willingness
to contribute to this endeavor was indicated by providers’
response to the first question of each survey which asked
for a “yes” response if they agreed to participate. Any sur-
veys in which a “no” response was chosen to this initial
question were considered “unusable” since consent had
not been given for participation. After the initial email was
sent inviting clinician participation, three additional
reminders were mailed every 10 days over the following
month to encourage survey completion. The de novo sur-
veys were initially piloted by three residents and two FCM
physicians that lead our campus’ Practice Based Research
Network (PBRN); approval of the PBRN was necessary
prior to distributing the survey. Several questions were
modified to enhance clarity of responses on the basis of
this trial.
The first survey was comprised of a total of 48 ques-
tions that were estimated to require 15 minutes to com-
plete. At the beginning of the survey, H/NP were defined
as: supplements containing plant-based herbals (e.g.,
Echinacea, St. John’s Wort, saw palmetto, garlic, ginger,
gingko, etc.), amino acids and their derivatives, probio-
tics, fish oils, and enzymes. On the other hand, clinicians
were specifically directed not to include multivitamin
products and minerals such as calcium, iron, or folate in
Boehmer and Karpa BMC Health Services Research 2011, 11:279
http://www.biomedcentral.com/1472-6963/11/279
Page 2 of 10the H/NP definition. The first survey began with 11
demographic questions, followed by 26 questions asses-
sing attitudes and practice experiences with respect to H/
NP, and the survey concluded with ten multiple choice
questions assessing knowledge about safety and efficacy
o fc o m m o n l yu s e dH / N P s .T h ef i r s ts u r v e yw a sc o n -
ducted in November and December, 2008.
The following year, the same clinical providers (MD,
DO, NP, PA) from the 3 departments were invited to
participate in a second survey, which was comprised of
ten demographic questions and twelve questions that
aimed to assess the utility of the NMCD, as well as
changes in opinions or practice experiences with respect
to H/NP that had occurred as a result of having access to
the electronic resource. Residents received this second
survey in May and June to capture their responses prior
to residency completion; the other providers received the
second survey in November and December of 2009. It
was estimated that 5-10 minutes was adequate for com-
pleting the second survey. No incentives were offered for
completing either survey. The study was granted exemp-
tion from oversight by the Investigational Review Board
of the Penn State University Milton S. Hershey Medical
Center (#29014EM; 8-4-2008) since data was collected in
an anonymous fashion.
Database
Immediately following the first survey, a subscription to
a web-based clinical decision H/NP tool (Natural Medi-
cines Comprehensive Database (NMCD), Stockton, CA)
was procured for the 2009 calendar year. The number
of “hits” that originated from Penn State - Hershey
internet protocol (IP) addresses was recorded by
NMCD.
In the first six months after subscribing to the NMCD, a
number of demonstrations were delivered across institu-
tional divisions to heighten awareness of the resource. Spe-
cifically, oral demonstrations were delivered at a Faculty
Organization meeting, as well as faculty meetings for the
Med divisions, a FCM faculty meeting, and a basic science
departmental faculty meeting. Additional demonstrations
of the electronic tool took place at staff meetings for both
nurse practice counsel and nurse managers. The NMCD
was also “advertised” in the campus newsletter, and fea-
tured as the main topic of the campus intranet for several
weeks. In addition, the NMCD was prominently displayed
and demonstrated at several physician and nursing tech-
nology fairs on campus and added to the FCM toolbar
within the patient electronic medical record. Furthermore,
special faculty seminars were jointly conducted between
staff librarians and pharmacology faculty to demonstrate
the clinical utility of the database to other allied health pro-
fessionals, including dieticians. Finally, three de novo elec-
tronic tutorials were created and prominently posted on
the campus library’s website to illustrate different features
of the database and the applicability of the tool to clinical
practice. http://www.pennstatehershey.org/web/library/
resources/natural-medicines-comprehensive-database.
Additionally, during the inaugural year in which the
NMCD was made available on our campus, numerous
emails targeting Med, FCM, and Ped providers were sent
reminding of the electronic tool.
Statistical Analysis
Initially, we hypothesized that clinicians would have
unmet educational needs with regard to H/NP in patient
encounters. Subsequently, we further surmised that an
electronic clinical decision support tool would help to
meet these needs. The statistical software package, SAS
version 9.1 (copyright by SAS Institute, Cary, NC), was
used to analyze the data. Descriptive statistics were gen-
erated including means, medians, and standard devia-
tions for continuous variables and frequency tables for
categorical variables. Differences between groups were
characterized using contingency table analysis; signifi-
cance levels were determined by Pearson’sc h i - s q u a r e
statistics and Fisher’s Exact tests. Significance was set at
p < 0.05.
Results
Baseline Attitudes, Practice Experiences, and Knowledge
with Herbal and Natural Products
A total of 532 providers, including 157 residents, were
invited to participate in the initial survey assessing needs,
attitudes, experiences, and knowledge of H/NP (Figure 1).
Responses were obtained from 89 of these practitioners
(16.7%). In addition to attending physicians, fourteen resi-
dent physicians responded, as well as ten nurse practi-
tioners and five physician’s assistants (collectively referred
to as respondents, providers, or clinicians herein). The
cohort of respondents was comprised of 20 individuals
from the pediatric division, 40 providers from internal
medicine, and 28 providers from FCM. Based upon the
sizes of these clinical departments, the highest response
r a t ew a so b t a i n e df r o mF C M ,w i t h3 4 %r e p l y i n gt ot h e
survey. In contrast, lower responses rates of 10% and 24%
came from the departments of pediatrics and internal
medicine, respectively. Demographic characteristics of the
respondents are depicted in Table 1.
Clinicians readily acknowledged that their patients uti-
lize H/NP, with the majority of respondents estimating
that 26 to 50% of their patients are using dietary supple-
ments. Despite recognizing that H/NP use is common
among their patients, however, nearly half of the respon-
dents (41%) indicated that they “never” or “rarely” ask
about H/NP when taking a patient history. The majority
of respondents (71%) estimated that they had discussed
H/NP with fewer than 25% of their patients. Moreover,
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initiated the conversation only 37% of the time. Seventy-
nine percent of respondents indicated that they “rarely”
or “never” recommend H/NP to patients, with the inter-
nists least likely of the three clinical divisions to recom-
mend dietary supplements to their patients. Ninety-five
percent of internal medicine providers reported that they
had “never” or “rarely” recommended H/NP to their
patients.
A large majority [n = 80 (92%)] of providers indicated
that, as health care practitioners, they should have knowl-
edge or, at least, access to accurate information about
common H/NP used by consumers. This attitude was
expressed by 100% of both Ped and FCM respondents but
only 82% of internists (p = 0.01)(Table 2). Fifty-eight
respondents (67%) expressed the opinion that knowledge
of H/NP can lead to more successful patient outcomes,
but only 43 (49%) clinicians felt that it was their responsi-
bility to counsel and provide information to patients about
the H/NP that they are using. Internists were less than
half as likely to agree that they should counsel patients
about H/NP compared to their Ped and Med colleagues (p
= 0.01; Table 2; 12 of 39 [31%] versus 13 of 20 [65%] ver-
sus 18 of 28 [64%], respectively).
In addition to differences in attitudes among clinicians
of different specialties, differences in H/NP attitudes were
also observed between providers of different genders, resi-
dents versus attending faculty, those who have been prac-
ticing the longest versus the shortest, physicians (MD,
DO) versus providers with other degrees (NP, PA), and
those trained in the USA versus other countries (Table 2).
Female practitioners indicated a greater likelihood than
their male counterparts to inquire about H/NP when tak-
ing a drug history (p = 0.01) (Table 2), and they exhibited
a heightened awareness of interactions and side effects (p
= 0.01) that H/NP can cause. Residents, on the other
hand, were less cognizant compared to attending faculty
(p = 0.04) of the potential for H/NP to interact with pre-
scription drugs and cause side effects. Residents were also
less likely to ask patients about H/NP use. Non-physician
providers were less aware of the potential for H/NP to
cause side effects (p = 0.006) and drug interactions (p =
0.02), but also tended to be more interested in acquiring
additional education about H/NP compared with physi-
cians (Table 2). Completion of medical training outside
the USA was also associated with a tendency toward hav-
ing a favorable view of the benefits of H/NP as compared
to their potential to cause side effects (Table 2).
Figure 1 Providers Invited to Participate in Herbal and Natural Product Assessment. (A) Initial Baseline Survey to assess H/NP attitudes,
experiences and knowledge in 2008. (B) Second Follow-up Survey to assess the extent the electronic tool changed attitudes, experiences, and
knowledge, 2009. FCM, Department of Family and Community Medicine; Peds, Department of Pediatrics; Int Med, Department of Internal
Medicine; R, residents.
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that they would like to learn more about H/NP. The
majority (63%) admitted that they know relatively little
about this topic, and only 10% expressed confidence in
their ability to accurately answer patient’sq u e s t i o n s
about H/NP.
To explore familiarity with common H/NP in ordinary
clinical scenarios, ten knowledge-based multiple-choice
questions modified from Shapiro [2] were included within
the survey. In addition to a correct answer and a series of
incorrect answers, an “Id o n ’tk n o w ” option was also
included. This option was added in attempt to keep provi-
ders from guessing at answers they did not know with cer-
tainty. Overall, providers in FCM achieved a greater
proportion of correct responses compared to the other
two clinical departments for most (eight) knowledge
questions (data not shown). Recognizing their knowledge
deficit, 74 respondents (86%) admitted that they would
feel more confident discussing H/NP with patients if they
had more education in this area. Furthermore, most (n =
80) practitioners (94%) indicated that they would feel
more confident discussing H/NP with patients if they had
access to an evidence-based tool that contained product
monographs.
In this baseline assessment ,t h em a j o r i t yo fs u r v e y
respondents (n = 62; 72%) admitted that they find it diffi-
cult to find reliable information about H/NP. Many (n =
54; 63%) responded that they would “absolutely” use an
evidence-based, electronic tool to evaluate safety or effi-
cacy of H/NP if one was made available through the uni-
versity. Only one individual indicated that such an
instrument would “definitely not” be of interest to them.
Table 1 Demographics of Survey Respondents
Responders to the Baseline Needs Assessment Survey in 2008 N (%) Responders to Follow-up Survey in 2009 N (%) p-value
Gender Gender 0.60
Male 46 (52) Male 41 (48)
Female 43 (48) Female 45 (52)
Age (years) Age 0.68
≤ 30 14 (16) ≤ 30 16 (18)
31-40 23 (26) 31-40 22 (25)
41-50 20 (22) 41-50 22 (25)
51-60 26 (30) 51-60 18 (21)
≥ 60 6 (7) ≥ 60 9(10)
Ethnicity Ethnicity 0.49
Asian 11 (13) Asian 10(12)
Bi-racial 1 (1) Bi-racial 0
Black 0 Black 2(2)
Caucasian 72 (83) Caucasian 69(81)
Hispanic 0 Hispanic 2(2)
Other 1 (1) Do not wish to answer 2(2)
Place of Training Place of Training 0.75
Inside USA 76 (85) Inside USA 74(87)
Outside USA 13 (15) Outside USA 11(13)
Provider’s Medical Degree Medical Degree 0.12
MD 68 (76) MD 69 (79)
DO 6 (7) DO 5 (6)
NP 10 (11) NP 5 (6)
PA 5 (6) PA 2 (2)
RN 3(4)
Others 3 (4)
Years Since Completion of Training Years Since Completion of Training 0.66
Still in residency/fellowship 14 (16) Still in residency/fellowship 18(21)
Under 5 18(20) Under 5 11(13)
6-15 24 (27) 6-15 26(3)
16-25 21 (24) 16-25 19(22)
Over 26 12 (13) Over 26 13(15)
Demographic characteristics of providers who responded to initial baseline survey and the second follow-up survey are shown. Percentages may be > or < 100%
due to rounding or absent responses. MD, medical doctor; DO, doctor of osteopathy; NP, nurse practitioner; PA, physician assistant; others, self-identified as
PharmDs, certified diabetic educators, and PhDs
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Gender Specialty Degree Training Years in Practice Rank
M
(%)
F
(%)
Ped
(%)
Int
Med
(%)
FCM
(%)
MD,
DO
(%)
NP,
PA
(%)
In
USA
(%)
Out of
USA
(%)
In residency/fellowship or
< 5 years post-training
(%)
5-15
years
(%)
>1 5
years
(%)
Resident
(%)
Board
Certified/
Eligible (%)
Practitioner knowledge of H/NP leads to better
patient outcomes
55 79† 70 59 75 64 80 67 67 75 67 58 72 62
Practitioners should have knowledge or accessibility
to information about common H/NP
86 98 100 82* 100 92 93 93 83 97 100 81* 100 90
Some herbal products hold promise for treatment of
medical conditions
71 79 90 64 79 74 80 79 50 75 96 58 ξ 79 74
Patient counseling about H/NP is the practitioner’s
responsibility
39 61

65 31 ψ 64 46 67 51 42 44 50 55 50 47
H/NP rarely cause side effects 81 51* 50 74 68 73 33 ξ 63 91 56 58 83  57 75
H/NP rarely interact with prescription drugs 67 47 45 63 56 63 27† 54 73 47 50 72 36 68
Would like to learn more about H/NP 72 91

85 74 89 77 100 83 73 91 88 67†† 93 74
Would feel more confident discussing H/NP with
formal training
81 91 90 82 89 85 93 88 73 94 92 73†† 93 82
Would feel more confident discussing H/NP with
access to a database that contained product
monographs
93 95 95 95 93 93 100 96 82 94 100 90 85 95
It is easy for me to find reliable information about H/
NP
37 19 30 13* 46 29 20 29 18 25 17 40 21 32
Would absolutely use an evidence-based tool to
evaluate H/NP if one was available
50 76
**
79 59 57 59 80 62 67 55 75 61 54 60
Always ask patients about H/NP when taking a drug
history
11 35* 25 23 21 21 33 23 25 13 38 23 14 21
When my patients and I discuss H/NP, I usually
initiate the conversation
36 37 35 41 32 35 47 41 8† 25 42 45 14 40
Often recommend H/NP to friends or relatives 2 16 21 3 11 9 13 9 8 6 9 13 7 9
Have personally used an H/NP within the past month 30 28 40 23 29 28 33 29 25 31 21 32 36 24
Provider attitudes and practice experiences with herbal and natural products vary with gender, specialty, degree, country of training, years in practice, and rank achieved. * p = 0.01; † p = 0.02; **p = 0.03; ††p=
0.04;  p = 0.05; ξ p = 0.006; ψ p = 0.007
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0Fifty-seven respondents (66%) indicated that their moti-
vation for using such a tool would be to recommend H/
NP that are safe and effective, and 45 respondents (52%)
indicated that dissuading patients from using unsafe or
ineffective H/NP was important to them.
Follow-Up Assessment: Second Survey
After having the NMCD available for six months, residents
in the departments of Ped, Med, and FCM were again
asked to participate in a follow-up assessment regarding
their views pertaining to the utility of the H/NP tool in
their practice. Other clinical providers in these depart-
ments were surveyed a year after the first survey had been
distributed. In total, 535 providers, including 150 residents
were invited to participate in the second survey (Figure 1).
Responses were obtained from 87 individuals (16.3%),
resulting in a similar response rate to that attained by the
initial survey. Respondents who indicated their departmen-
tal affiliations represented Ped (n = 33), Med (n = 23),
FCM (n = 27), as well as clinical psychology (n = 1) and
the pharmacy (n = 1) (responses from these later 2 provi-
ders were not included in subsequent data analysis). Over-
all the demographic characteristics of those that responded
to the baseline survey and the follow-up survey were simi-
lar (Table 1); however, the two groups of respondents were
not identical. Thirty-three individuals (39%) indicated that
they had responded to the baseline survey, but 21 (24%)
indicated they had not participated previously, and 32
(37%) admitted that they could not remember. When the
number of respondents was considered as a function of
departmental size, the highest response rate (30%) was
again obtained from providers in FCM.
Of those who responded to the follow-up survey, 55
(63%) indicated that they had not used the NMCD.
Among this group, the most frequent reason cited for not
using the tool was lack of awareness of the tool (n = 26;
50%). Seven additional respondents (n = 14%) indicated
that while they had not personally used the database, they
had asked a student or nurse to use the NMCD for them.
Other reasons for not using the database were that no
patients had inquired about H/NP (17 respondents), and
two clinicians responded that they discourage all H/NP
usage. Even among this group of individuals who had not
used the H/NP database, 46 providers (85%) were of the
opinion that the NMCD is a valuable tool when questions
or concerns about dietary supplements arise. No demo-
graphic differences were apparent between respondents
who had used the tool and those who did not. Of survey
respondents who had used the H/NP tool, the greatest
percentage of users was from the department of FCM
(44% of survey respondents from FCM had used the tool).
Ninety-seven percent (31 of 32) of clinicians who had
used the database found the tool improved their ability
to find evidence-based information about H/NP, 91%
reported that having the tool available increased their
confidence when talking about H/NP with patients or
colleagues, and 94% thought that the database had
increased their overall knowledge of H/NP. Compared
to respondents from the baseline survey, the electronic
database significantly increased clinicians’ ability to find
reliable H/NP information (P < 0.0001), improved self-
rated knowledge of H/NP (p < 0.0001) and increased
clinician confidence when discussing H/NP with others
(P < 0.0001) (Table 3).
As a result of having the NMCD available to look up H/
NP, 63% of those who used the database indicated that
they are now more likely to ask patients about H/NP
when taking a drug history and the same percentage indi-
cated that since having the NMCD tool, they have dis-
cussed H/NP with patients more often. Eighty-eight
percent (28 of 32) of database users feel that having an evi-
dence-based H/NP tool available has improved the quality
of care that they provide to their patients.
Having the NMCD available to assist in evidence-based
evaluations of H/NP also led to changes in clinical prac-
tice. Eleven respondents (33%) indicated that the database
increased their likelihood of recommending H/NP to
patients for medicinal purposes, whereas two respondents
Table 3 Perceptions of a Natural Product Database Tool: Before and After
Pre N (%) Post N (%) P value
Would/did use the NMCD 54 (98) 32 (36) < 0.0001
Would/did use for NMCD for patient safety (i.e. adverse effects) 44 (51) 20 (65) P = 0.12
Would/did use NMCD to evaluate H/NP efficacy 45 (52) 27 (84) P = 0.0033
Would/did use NMCD to identify ingredients in a trade name product 56 (64) 24 (75) P = 0.0004
Would/did use NMCD to identify interactions 67 (77) 24 (77) P = 0.1588
Would/did use NMCD to indentify contraindications 64 (74) 29 (90) P = 0.1095
Uneasy discussing H/NP with patients/the NMCD has increased my confidence when talking about H/NP 35 (41) 29 (91) P < 0.0001
Perceived knowledge of H/NP/the NMCD increased my knowledge of H/NP 32 (37) 30 (94) P < 0.0001
It is easy to find reliable H/NP info/the NMCD improves ability to find reliable H/NP information 24 (28) 31 (97) P < 0.0001
A priori perceptions of the utility of a H/NP tool and reported utilization. Data shown reflects affirmative responses; neutral responses were not included in
analysis. Not all respondents answered every question.
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mation about H/NP, the database decreased the likelihood
that they would recommend an H/NP. Two respondents
admitted that as a result of using the database, they per-
sonally started using H/NP, while one respondent indi-
cated that s/he had personally stopped using a dietary
supplement as a result of the tool.
Regardless of whether respondents had personally used
the NMCD tool, 95% (83 of 87) indicated that the resource
has potential to improve patient care. Overall, 12,337 page
views on the NMCD originated from the PSU Hershey
campus over the course of the year-long trial subscription,
averaging more than 1,000 page views per month, and 81
of the 87 respondents (94%) were of the opinion that the
initial trial subscription of the resource should continue.
According to survey respondents, the most useful features
of the NMCD pertained to efficacy data and identifying
contraindications. Providers also relied upon the tool to
identify individual ingredients in trade name products,
identify adverse effects, and identify drug interactions
(Table 3). Notably, more than 50% of clinicians had
selected these items among their H/NP needs in the initial
survey. Other frequently reported uses of the database
included identifying appropriate doses of H/NP (19 of 33;
59%) and identifying putative mechanisms of action (22 of
33; 69%) for supplements. Nearly half of those who had
used the database (47%) used the tool to print educational
handouts for patients; additionally, three providers (9%)
used the tool to identify United States Pharmacopeia
(USP)-verified supplements to assure that high-quality
products were recommended to patients.
Discussion
Our study is the first to assess faculty attitudes, needs,
and practice experiences with H/NP before and after
implementing a solution to the H/NP needs that clini-
cians face. Furthermore, we are only the second group
to explore physician acceptance, experiences, and
knowledge of dietary supplements within an academic
medical center [8,13,18].
Based upon responses obtained by our surveys, at our
medical center, the NMCD tool appeared to be of greatest
relevance to FCM providers. The openness and interest of
FCM clinicians to nontraditional therapeutic alternatives
may reflect a philosophical difference between FCM and
other specialties, as this group of physicians tends to place
great emphasis on developing, nurturing, and maintaining
patient-centered relationships. Therefore, rather than sim-
ply disavowing use of all dietary supplements, it is impor-
tant for FCM physicians to know about these alternatives
in order to foster patient relationships. In contrast, our
data found that our Med colleagues were less inclined to
participate in our surveys and less likely to perceive H/NP
knowledge as integral to the healthcare that they provide.
T h i sm a yr e f l e c tt h er o l eo fi n t e r n i s t sa s“specialists” as
opposed to generalists. In the “specialist” culture, there is
generally less emphasis on comprehensive care to patients
across the lifespan, as the care is often limited by age, gen-
der, or affected organ.
Our intent in this endeavor was not to create physician
specialists in H/NP prescribing, but rather, was to simply
examine changes in clinician attitudes and experiences
toward dietary supplements when provided with access to
a tool that could be utilized and applied at the point-of-
patient-care. Based upon before and after comparisons of
providers practicing in three clinical departments, we
observed that access to the NMCD increased confidence
when discussing H/NP with patients, increased self-
reported knowledge of H/NP, and increased the likelihood
of providers asking about H/NP when taking a drug his-
tory. We chose the NMCD because it had previously been
found to be superior to other available electronic tools in
terms of scope and completeness; additionally, it is report-
edly the H/NP tool of choice by drug information centers
[19-21].
Despite numerous faculty education sessions, demon-
strations, and training modules that were created and
delivered around the campus to demonstrate the utility of
the NMCD, we were surprised that 63% of providers indi-
cated on the follow-up survey that they were unaware that
this resource existed. A subsequent questionnaire sent to
all physicians inquired about the preferred method of
communication about new resources; overwhelmingly,
respondents indicated email as the preferred medium. We
had extensively used e-mail to describe and to “advertise”
the database and the opportunities that were available to
learn more about this tool. Considering the deluge of
email that is common, perhaps we should not be surprised
at the poor communication afforded by this communica-
tion method. Communication difficulties regarding new
endeavours are apparently not unique at our institution
[22]. Wahner-Roedler et al. [23] reported that 49% of phy-
sicians at Mayo Clinic found it difficult to find reliable
information about herbs, despite the institution having
subscribed to a web-based resource for many years. Col-
lectively, these experiences demonstrate the need for bet-
ter intra-institutional methods of communication.
Limitations to our evaluation exist. First, the response
rate among providers at our institution was lower than
anticipated. Our response rate was similar, however, to
that of Chan and Wong, in their evaluation of physician
attitudes, practices, and training with respect to a wide
range of complementary and alternative medicine (CAM)
practices [24]. These low response rates may reflect an
unspoken perception that CAM, including H/NP, does
not have a place within academic medical centers. Given
that we do not have access to demographic data from the
non-responders, we do not know if any distinguishing
Boehmer and Karpa BMC Health Services Research 2011, 11:279
http://www.biomedcentral.com/1472-6963/11/279
Page 8 of 10characteristics (gender, age, training, etc.) would differ-
entiate responders from non-responders. Nonetheless,
our response rate was nearly identical for both the base-
line assessment and the follow-up. Given our response
rate, self-selection bias may have occurred, leading to
over-representation of responses among those with the
strongest feelings (pro or con) about H/NP. Another lim-
itation to the dataset may have occurred with respect to
the knowledge assessment. It is conceivable that inclu-
sion of the “Id o n ’tk n o w ” option may have decreased
overall knowledge scores. While our intent by including
this selection was to limit provider “guessing”,i ti sp o s s i -
ble that responders may have selected this response in
haste to complete the survey instrument. Nonetheless,
we believe it is probable that our clinicians truly did not
know the correct answers to the knowledge questions
about commonly-used H/NP since similar knowledge
scores have been identified at other institutions [23].
We recognize that the initiative that we described may
not be necessary at institutions that have Integrated
Health Centers (and presumably a wider array of CAM
resources). Nonetheless, for medical centers such as ours,
the NMCD can be a valuable tool. In addition, we recog-
nize that implementing clinical decision tools such as the
NMCD can be limited by cost at some medical centers.
Economic and financial aspects are important considera-
tions, yet, we believe that the utility of such a tool can
outweighs the economic impact.
Conclusions
In conclusion, we have found that using a web-based
resource to find accurate information about H/NP in the
context of patient care has improved clinician confidence
discussing H/NP, increased the likelihood that providers
inquire about H/NP when taking drug histories, and
increased clinicians’ perception of the quality of care they
can provide to patients. With the dynamic environment
that surrounds consumer use of H/NP, electronic decision
tools may be a critical element to meet clinical needs.
Patients that visit academic medical centers tend to have
complex medical problems and chronic illnesses; they are
precisely the population of patients that resort to using H/
NP when they perceive that conventional medicine has
failed them. In academic settings, it may be especially
important for clinicians to consider the impact of H/NP in
patient care. Our data indicate that providers do not
necessarily need to master additional coursework in the
area of H/NP; simply having access to an evidence-based
H/NP decision tool can aid therapeutic discussions and
inform decisions that can rationally guide patient care.
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